Forepont Capital
Finance · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
230 Park Ave Fl 3, New York City, New Yo...Website
www.forepont.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
2
1
1
1
1
About Forepont Capital
Founded in 2017 in New York, Forepont Capital Partners is a global asset manager specializing in healthcare and life sciences. The company invests in biotech, medtech, and e-health start-ups in the United States and Europe, providing them with scientific, technological, financial, and operational support. Forepont has established strong partnerships with industry leaders, which enhance their investment strategy and contribute to the discovery of new treatments. Their mission is to improve patient lives through innovative medical research and the performance of their invested start-ups.Explore more
Forepont Capital Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Forepont Capital your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Forepont Capital had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Forepont Capital launches new products
Check out if Forepont Capital is spiking on competitors!
Check if Forepont Capital has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Forepont Capital
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Forepont Capital, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Forepont Capital recently announced quarterly report
Funding: Get notified immidiatlly once Forepont Capital has new funding data
Recommended Actions
Find VP level buyers at Forepont Capital
Find more new buyers
Compare Similar Companies to Forepont Capital
Compare insights from companies similar to Forepont Capital, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Forepont Capital is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Forepont Capital is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Forepont Capital.
Forepont Capital Tech Stack
A closer look at the technologies used by Forepont Capital
See more technologies
Most Recent Scoops
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Forepont Capital News & Media
AlterDiag, a company financially backed by Forepont Capital Partner (FCP), announces the signature of a strategic partnership with the Institut Pasteur on research and development of next generation rapid diagnostic technologies for the diagnosis of infectious diseases
AlterDiag & Institut Pasteur partner to develop next-gen rapid tests using VHH antibodies for infectious disease diagnosis & global health impact.BCV Raises €6M Series A
PARIS & NEW YORK--(BUSINESS WIRE)--BCV has secured €6 million Series A to develop the first mechatronic Guidewire for endovascular access during minimally invasive procedures.Synchron Raises $75M in Series C Funding
Synchron, a New York-based endovascular brain-computer interface (BCI) company, raised $75M in Series C funding. The investor syndicate included new investors ARCH Venture Partners, Gates Frontier, Bezos Expeditions, Reliance Digital Health Limited, Greenoaks, Alumni Ventures, Moore Strategic Ventures, and Project X, with follow on participation from existing investors including Khosla Ventures, NeuroTechnology Investors, METIS, Forepont […] The post Synchron Raises $75M in Series C Funding appeSynchron Raises $40M in Series B Funding
Synchron, a New York-based company developer of brain interface platforms, raised $40M in series B funding. The round, which brought the total amount raised since company formation to $59m, was led by Khosla Ventures with participation from Forepont Capital Partners, ID8 Investments, Shanda Group, General Advance, Subversive Capital (Michael Auerbach), re.Mind Capital (Christian Angermayer), as […] The post Synchron Raises $40M in Series B Funding appeared first on FinSMEs.
Read more news
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Forepont Capital
Sign Up For FreeTo access detailed company insights
Founded in 2017 in New York, Forepont Capital Partners is a global asset manager specializing in healthcare and life sciences. The company invests in biotech, medtech, and e-health start-ups in the United States and Europe, providing them with scientific, technological, financial, and operational support. Forepont has established strong partnership... Read More
